Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1041

1.
2.

Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N, Leprisé PY, François S, Cony-Makhoul P, Harousseau JL, et al.

Blood. 1995 Feb 1;85(3):664-74.

3.

[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].

Sun XF, Zhen ZJ, Liu DG, Xia ZJ, Huang HQ, Zhang L, Zhou ZM, Li YH, Xia Y, Ling JY, Guan ZZ.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):58-61. Chinese.

PMID:
17575697
4.

Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.

Vecchi V, Serra L, Pession A, Rosito P, Paolucci P, Burnelli R, Vivarelli F, Mancini AF, Paolucci G.

Pediatr Hematol Oncol. 1986;3(3):217-28.

PMID:
3153234
5.

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphaël M, Terrier-Lacombe MJ; Société Française d'Oncologie Pédiatrique.

Blood. 2001 Jun 1;97(11):3370-9.

6.

Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).

Sullivan MP, Boyett J, Pullen J, Crist W, Doering EJ, Trueworthy R, Hvizdala E, Ruymann F, Steuber CP.

Cancer. 1985 Jan 15;55(2):323-36.

7.

Primary peripheral nodal lymphoma in children.

Wollner N, Exelby P, Lindsley KL, Lieberman P, Filippa D, Heller G.

Cancer. 1993 Jun 1;71(11):3670-9.

8.
9.

The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.

Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM.

Cancer. 2002 May 15;94(10):2738-44.

10.
11.

Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.

Neth O, Seidemann K, Jansen P, Mann G, Tiemann M, Ludwig WD, Riehm H, Reiter A.

Med Pediatr Oncol. 2000 Jul;35(1):20-7.

PMID:
10881003
12.

[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].

Sun XF, Jiang WQ, Liu DG, Xia ZJ, Huang HQ, Zhang L, Li YH, Zhou ZM, Zhen ZJ, Xia Y, He YJ, Guan ZZ.

Ai Zheng. 2004 Dec;23(12):1687-91. Chinese.

PMID:
15601561
13.

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.

Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE.

Med Pediatr Oncol. 2001 Nov;37(5):432-41.

PMID:
11745871
14.

Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.

Patte C, Kalifa C, Flamant F, Hartmann O, Brugières L, Valteau-Couanet D, Bayle C, Caillaud JM, Lemerle J.

Med Pediatr Oncol. 1992;20(2):105-13.

PMID:
1734214
15.

Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

Chen YC, Ho CL, Kao WY, Hwang JM, Sheu LF, Chao TY.

Ann Hematol. 2001 Nov;80(11):647-52.

PMID:
11757723
16.

[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].

Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y.

Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):469-73. Chinese.

PMID:
19950562
17.

[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].

Starý J, Gajdos P, Blazek B, Ptoszková H, Mihál V, Pospísilová D, Hrstková H, Dembická D, Kopecná L, Slavík Z, Hak J, Procházková D, Zahálka F, Cerná Z, Jabali Y, Timr P, Vávra V, Mydlil J, Hrusák O, Trka J.

Cas Lek Cesk. 2003;142(7):404-9. Czech.

PMID:
14515443
18.

Nasal-paranasal-oronasopharyngeal lymphomas in childhood: the role of staging system on prognosis.

Yariş N, Kutluk T, Yalçin B, Akyüz C, Büyükpamukçu M.

Pediatr Hematol Oncol. 2000 Jul-Aug;17(5):345-53.

PMID:
10914044
19.

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.

Atra A, Imeson JD, Hobson R, Gerrard M, Hann IM, Eden OB, Carter RL, Pinkerton CR.

Br J Cancer. 2000 Apr;82(8):1396-402.

20.

Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.

Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A; BFM-Group.

Ann Hematol. 2001;80 Suppl 3:B73-6.

PMID:
11757713

Supplemental Content

Support Center